CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ)

$0.0211 -0.0004 (-1.8605%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) News Sources

CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing

05-11-2025

yahoo.com

CERo Therapeutics Announces Trading on OTCQB Market

02-12-2025

yahoo.com

CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)

17-12-2025

yahoo.com

CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML

07-01-2026

yahoo.com

CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient

04-02-2026

yahoo.com

CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

17-02-2026

yahoo.com

CERo Therapeutics Provides Shareholder Update

11-03-2026

yahoo.com

CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial

30-03-2026

yahoo.com

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial

14-04-2026

yahoo.com

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial

11-05-2026

yahoo.com

CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) Sentiment Trend

0 25 50 75 100 85 69 86 81 85 83 87 90 90 87 05-11-2025 02-12-2025 17-12-2025 07-01-2026 04-02-2026 17-02-2026 11-03-2026 30-03-2026 14-04-2026 11-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) FAQs

toggle

What is the current price of CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ)?

The current price of CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) is $0.0211.


toggle

CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) absolute price change since previous trading day?

The absolute price change of CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) since the previous trading day is $-0.0004.


toggle

CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) percentage price change since previous trading day?

The percentage price change of CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) since the previous trading day is -1.8605%.


toggle

What is the most recent average sentiment score for CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ)?

The most recent average sentiment score for CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) is 84 out of 100.


toggle

What is the most recent average sentiment for CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ)?

The most recent sentiment for CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ) is .


SEC-8K** Filing Available For CERO THERAPEUTICS HOLDINGS I (CERO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.